文献速递炎症性肠病

溃疡性结肠炎患者可发生组织学正常化,并与临床结局改善相关

Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-02-24

该回顾性研究纳入646例确诊溃疡性结肠炎患者,评估组织学正常化的患病率及其与临床复发的关系。研究发现10%患者达到组织学正常化,且与组织学静止期相比,组织学正常化与无复发生存几率增加独立相关;但黏膜愈合与无黏膜愈合相比无此关联。作者结论认为组织学正常化可作为临床终点,但需进一步研究其是否应作为治疗目标。

要点

  • 646例溃疡性结肠炎患者中,10%达到组织学正常化,40%为组织学静止期。
  • 组织学正常化与无复发生存几率增加独立相关(vs 组织学静止期 HR 4.31;vs 组织学活动 HR 6.69)。
  • 黏膜愈合与无黏膜愈合相比,无复发生存几率无显著差异(HR 1.02)。

核心结论

  • 结肠黏膜组织学正常化可作为溃疡性结肠炎患者的临床终点。
  • 与内镜下黏膜愈合或组织学静止期相比,组织学正常化与无复发生存几率增加相关。
  • 需进一步研究以确定组织学正常化是否应作为溃疡性结肠炎患者的治疗目标。

研究设计与样本

  • 回顾性研究,纳入2005年8月至2013年10月在一家三级医疗中心接受结肠镜检查的646例确诊溃疡性结肠炎患者。
  • 根据组织学表现将随机黏膜活检分为3组:正常化(完全正常黏膜,无慢性化特征)、静止期(隐窝萎缩或分支,无活动性炎症迹象包括糜烂、脓肿或局灶性中性粒细胞浸润)、活动性疾病(中性粒细胞上皮浸润、隐窝脓肿、糜烂或溃疡)。
  • 比较组织学表现与临床及内镜表现,评估与组织学表现相关的变量。
  • 在临床缓解(Simple Clinical Colitis Activity Index评分≤2且排便频率或直肠出血子评分≤1)的患者中,计算随访6个月或更长时间后临床复发的预测价值。

主要发现

  • 646例患者中,60%达到内镜下黏膜愈合,40%为组织学静止期,10%为组织学正常化。
  • 黏膜活动性与组织学活动性之间的一致性为中等(68%样本一致;κ=0.50;P<.001)。
  • 多变量分析中,仅直肠炎与组织学正常化相关(P=.002)。
  • 初始评估时310例临床缓解患者中,中位时间16个月(四分位距10-23个月)后25%出现临床复发。
  • 与组织学静止期相比,组织学正常化与无复发生存几率增加独立相关(风险比4.31;95%置信区间1.48-12.46;P=.007);与组织学活动相比(风险比6.69;95%置信区间2.16-20.62;P=.001)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者结论指出组织学正常化可作为溃疡性结肠炎患者的临床终点,但需进一步研究确定其是否应作为治疗目标。

局限性

  • 需进一步研究以确定组织学正常化是否应作为溃疡性结肠炎患者的治疗目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Mucosal healing, determined by histologic analysis, is a potential therapeutic target for patients with ulcerative colitis (UC). However, the histologic features of tissue normalization, as an outcome of treatment, have not been well described. We examined the prevalence and predictive values of normalization of the colonic mucosa, based on histologic analysis (histologic normalization) in patients with UC, and determined its association with risk of clinical relapse, compared with histologic disease quiescence and endoscopic mucosal healing. METHODS: We performed a retrospective study of 646 patients with confirmed UC who underwent colonoscopy at a tertiary medical center from August 2005 through October 2013. We reviewed reports from pathology analyses of random mucosal biopsies from each colon segment, and categorized them into 3 groups based on histology findings: (1) normalization (completely normal mucosa with no features of chronicity present), (2) quiescence (crypt atrophy or branching without signs of active inflammation including erosions, abscesses, or focal neutrophil infiltration), or (3) active disease (epithelial infiltration by neutrophils, crypt abscesses, erosions, or ulceration). Histology findings were compared with clinical and endoscopic findings. We assessed variables associated with histology findings and, in patients in clinical remission (Simple Clinical Colitis Activity Index score ≤2 and subscore of ≤1 for stool frequency or rectal bleeding), predictive values for clinical relapse at follow-up evaluations 6 months later or more were calculated. RESULTS: Of the 646 patients included in the study, 60% had endoscopic mucosal healing, 40% had histologic quiescence, and 10% had histologic normalization. The level of agreement between mucosal and histologic activity was moderate (agreement for 68% of samples; κ = 0.50; P < .001). On multivariate analysis, only proctitis associated with histologic normalization (P = .002). Of 310 patients in clinical remission at initial review, 25% had a clinical relapse, after a median time of 16 months (interquartile range, 10-23 months). Histologic normalization was independently associated with increased odds of relapse-free survival compared with histologic quiescence (hazard ratio, 4.31; 95% confidence interval, 1.48-12.46; P = .007) and histologic activity (hazard ratio, 6.69; 95% confidence interval, 2.16-20.62; P = .001); mucosal healing was not associated with increased odds of relapse-free survival compared with no mucosal healing (hazard ratio, 1.02; 95% confidence interval, 0.56-1.85; P = .954). CONCLUSIONS: Histologic normalization of colonic mucosa can be used as a clinical endpoint for patients with UC. We associated histologic normalization with increased odds of relapse-free survival compared with endoscopic healing or histologic quiescence. Further studies are needed to determine whether histologic normalization should be a goal of treatment for patients with UC.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Christensen B, Hanauer SB, Erlich J, et al. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes. Clin Gastroenterol Hepatol. 2017. PMID: 28238954. doi:10.1016/j.cgh.2017.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。